Protalix and Pfizer's Gaucher drug Elelyso receives FDA approval

The FDA approved Protalix BioTherapeutics and Pfizer's injectable drug Elelyso to treat patients with type 1 Gaucher disease. Elelyso will be Protalix's first drug on the market.

View Full Article in:

Protalix Wins FDA Approval for Its First Drug on the Market - Bloomberg

Published in Briefs: